Uniqure NV
QURE
$44.31+0.70%
End of day · as of Sep 22, 2026, 8:01 AM ET
Mkt cap
$3.04B
EV/Sales
186.8
P/E ratio
N/A
FY2025 Revenue
$16.10M
EPS (9mo ended 2025-09-30)
$-2.90
Gross Margin (FY2025)
89.53%
Profit Margin (FY2025)
-1236.00%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Uniqure NV (QURE) is a biotechnology company listed on NASDAQ.
Latest reported QURE revenue for 2025-12-31 was $16.1M. Net income was -$199.0M. Revenue was down 40.6% from 2024-12-31 to 2025-12-31. QURE currently screens at market cap $3.04B.
Use this QURE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full QURE income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Uniqure NV (QURE) is a biotechnology company in the Healthcare sector.
Latest cached Uniqure NV (QURE) revenue for Dec 31, 2025 was $16.1M. Net income was -$199.0M. Statements: https://lician.com/financials/qure
Uniqure NV (QURE) market capitalization is $3.04B on the latest cached snapshot.
Uniqure NV (QURE) cached previous close $44.00; day range $43.81 – $45.03; volume 782,960. Session quote: https://lician.com/quote/qure
Uniqure NV (QURE) latest cached earnings event is "QURE earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached QURE filing is 8-K · Sep 29, 2026. Filings: https://lician.com/sec/qure